Praram 9 Hospital Public Company Limited

THAMSE:PR9-F Stock Report

Market Cap: ฿14.0b

Praram 9 Hospital Valuation

Is PR9-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PR9-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PR9-F (THB18.9) is trading below our estimate of fair value (THB19.51)

Significantly Below Fair Value: PR9-F is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PR9-F?

Key metric: As PR9-F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PR9-F. This is calculated by dividing PR9-F's market cap by their current earnings.
What is PR9-F's PE Ratio?
PE Ratio26.9x
Earnings฿519.38m
Market Cap฿14.00b

Price to Earnings Ratio vs Peers

How does PR9-F's PE Ratio compare to its peers?

The above table shows the PE ratio for PR9-F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.3x
MASTER Master Style
27.2x17.9%฿12.7b
SKR Sikarin
22.4xn/a฿18.9b
WPH Wattanapat Hospital Trang
25.5xn/a฿6.5b
CMR Chiang Mai Ram Medical Business
26.2xn/a฿7.2b
PR9-F Praram 9 Hospital
26.9x11.7%฿14.0b

Price-To-Earnings vs Peers: PR9-F is good value based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (38.9x).


Price to Earnings Ratio vs Industry

How does PR9-F's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
PR9-F 26.9xIndustry Avg. 21.8xNo. of Companies7PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PR9-F is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the TH Healthcare industry average (26.1x).


Price to Earnings Ratio vs Fair Ratio

What is PR9-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PR9-F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PR9-F's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies